Persistent	persistent	O	O	O	O
paralysis	paralysis	O	DISEASE	OTHERS	I
after	after	O	O	O	O
prolonged	prolonged	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
atracurium	atracurium	O	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
absence	absence	O	O	O	O
of	of	O	O	O	O
corticosteroids	corticosteroids	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Neuromuscular	neuromuscular	CHEMICALS	O	OTHERS	I
blocking	blocking	CHEMICALS	O	OTHERS	I
agents	agents	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
NMBAs	nmbas	O	O	O	O
)	)	O	O	O	O
are	are	O	O	O	O
often	often	O	O	O	O
used	used	O	O	O	O
for	for	O	O	O	O
patients	patients	O	O	O	O
requiring	requiring	O	O	O	O
prolonged	prolonged	O	O	O	O
mechanical	mechanical	O	O	O	O
ventilation	ventilation	O	O	O	O
.	.	O	O	O	O

Reports	reports	O	O	O	O
of	of	O	O	O	O
persistent	persistent	O	O	O	O
paralysis	paralysis	O	DISEASE	OTHERS	I
after	after	O	O	O	O
the	the	O	O	O	O
discontinuance	discontinuance	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
drugs	drugs	O	O	O	O
have	have	O	O	O	O
most	most	O	O	O	O
often	often	O	O	O	O
involved	involved	O	O	O	O
aminosteroid-based	aminosteroid-based	O	O	O	O
NMBAs	nmbas	O	O	O	O
such	such	O	O	O	O
as	as	O	O	O	O
vecuronium	vecuronium	CHEMICALS	O	OTHERS	I
bromide	bromide	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
especially	especially	O	O	O	O
when	when	O	O	O	O
used	used	O	O	O	O
in	in	O	O	O	O
conjunction	conjunction	O	O	O	O
with	with	O	O	O	O
corticosteroids	corticosteroids	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Atracurium	atracurium	O	O	OTHERS	I
besylate	besylate	O	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
short-acting	short-acting	O	O	O	O
benzylisoquinolinium	benzylisoquinolinium	O	O	OTHERS	I
NMBA	nmba	O	O	O	O
that	that	O	O	O	O
is	is	O	O	O	O
eliminated	eliminated	O	O	O	O
independently	independently	O	O	O	O
of	of	O	O	O	O
renal	renal	O	O	O	O
or	or	O	O	O	O
hepatic	hepatic	O	O	O	O
function	function	O	O	O	O
,	,	O	O	O	O
has	has	O	O	O	O
also	also	O	O	O	O
been	been	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
persistent	persistent	O	O	O	O
paralysis	paralysis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
but	but	O	O	O	O
only	only	O	O	O	O
when	when	O	O	O	O
used	used	O	O	O	O
with	with	O	O	O	O
corticosteroids	corticosteroids	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
atracurium-related	atracurium-related	O	O	O	O
paralysis	paralysis	O	DISEASE	OTHERS	I
persisting	persisting	O	O	O	O
for	for	O	O	O	O
approximately	approximately	O	O	O	O
50	50	O	O	O	O
hours	hours	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
patient	patient	O	O	O	O
who	who	O	O	O	O
was	was	O	O	O	O
not	not	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
corticosteroids	corticosteroids	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

